Trials / Completed
CompletedNCT00514995
Sodium Oxybate in the Treatment of Binge Eating Disorder
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Lindner Center of HOPE · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to study the effectiveness, tolerability and safety of sodium oxybate in outpatients with binge eating disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Oxybate | 4.5 g/night - 9 g/night, liquid taken twice per night |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2007-08-10
- Last updated
- 2011-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00514995. Inclusion in this directory is not an endorsement.